广发纳斯达克生物科技人民币(001092)
动态评分： 5.23分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2021-12-31 | UTHR | 联合治疗 | 100.84 | 0.7% |
| 2021-12-31 | GH | Guardant Health Inc | 97.57 | 0.68% |
| 2021-12-31 | JAZZ | 爵士制药 | 86.34 | 0.6% |
| 2021-12-31 | NBIX | 神经分泌生物科学 | 86.01 | 0.6% |
| 2021-12-31 | NTLA | Intellia Therapeutics Inc | 82.17 | 0.57% |
| 2021-12-31 | MEDP | Medpace Holdings Inc | 80.34 | 0.56% |
| 2021-12-31 | MRTX | Mirati Therapeutics Inc | 78 | 0.54% |
| 2021-12-31 | SRPT | Sarepta Therapeutics Inc | 74.41 | 0.52% |
| 2021-12-31 | ASND | Ascendis Pharma AS ADR | 75.31 | 0.52% |
| 2021-12-31 | BPMC | Blueprint Medicines Corp | 71.64 | 0.5% |
| 2021-12-31 | ARWR | Arrowhead Pharmaceuticals Inc | 70.09 | 0.49% |
| 2021-12-31 | HALO | 奥洛兹美医疗 | 65.27 | 0.45% |
| 2021-12-31 | CRSP | CRISPR Therapeutics AG | 64.26 | 0.44% |
| 2021-12-31 | BEAM | Beam Therapeutics Inc | 62.04 | 0.43% |
| 2021-12-31 | EXEL | 伊克力西斯 | 60.24 | 0.42% |
| 2021-12-31 | ARNA | Arena Pharmaceuticals Inc | 59.43 | 0.41% |
| 2021-12-31 | DNLI | Denali Therapeutics Inc | 59.86 | 0.41% |
| 2021-12-31 | FATE | Fate Therapeutics Inc | 57.86 | 0.4% |
| 2021-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 58.17 | 0.4% |
| 2021-12-31 | VIR | Vir Biotechnology Inc | 55.37 | 0.38% |
公告&资料